Rituximab With or Without Chemotherapy for Anti-MAG Neuropathy: A Retrospective Multicenter Real-World Study. (PubMed, J Peripher Nerv Syst) - Oct 1, 2026 - "In this cohort, adding chemotherapy to RTX was not associated with greater long-term improvement, despite a higher rate of adverse events. Prospective controlled studies are needed."
Journal • Real-world evidence • Retrospective data • Pain
|
|
Attarian Shahram; Aurran Schleinitz Thérèse; Boucraut José; Bouhour Françoise; Camdessanché Jean-Philippe; Cassereau Julien; Chanson Jean-Baptiste; Cintas Pascal; Cluse Florent; Delmont Emilien; Dormeuil Alice; Echaniz-Laguna Andoni; Farnault Laure; Fortanier Etienne; Frachet Simon; Gendre Thierry; Grapperon Aude-Marie; Labeyrie Céline; Magot Armelle; Magy Laurent; Mallaret Martial; Noel Nicolas; Noury Jean-Baptiste; Pegat Antoine; Planté-Bordeneuve Violaine; Poncet-Megemont Louis; Puma Angela; Stojkovic Tanya; Svahn Juliette; Taieb Guillaume; Tard Céline
|